Mon. 23 Mar 2026
🌫️ 3°C in Columbus
Date: 22-apr-2025 | By: Nuztrend Team
Image By Michielverbeek - Own work, CC BY-SA 4.0, Link
Roche Holding AG has unveiled plans to invest $50 billion in the United States over the next five years. This substantial investment will enhance the company's manufacturing and research capabilities, with new and expanded facilities planned in Indiana, Pennsylvania, Massachusetts, and California. The initiative is expected to create over 12,000 jobs, including approximately 6,500 construction positions and 1,000 roles within Roche's new and existing facilities.
With this investment, Roche aims to strengthen its U.S. manufacturing and distribution capabilities. The company anticipates that once the new and expanded facilities are operational, it will export more medicines from the U.S. than it imports, marking a significant shift in its production and distribution strategy.
Roche's investment aligns with efforts to encourage foreign companies to expand their operations within the United States, particularly in response to tariff policies aimed at boosting domestic manufacturing. This move follows similar investments by other pharmaceutical companies seeking to enhance their U.S. presence.
No comments yet! Be the first one to comment.
Date: 22-Apr-2025
Nomura Holdings announces its largest acquisition, purchasing Macquarie Group's U.S. and European public asset management businesses for $1.8 billion to bolster global investment capabilities.
Date: 22-Apr-2025
The U.S. has finalized steep tariffs—up to 3,521%—on solar panels from Southeast Asia to counter unfair trade practices, shaking the global solar supply chain.
